Your browser doesn't support javascript.
loading
LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model.
Huang, Ruea-Yea; Eppolito, Cheryl; Lele, Shashikant; Shrikant, Protul; Matsuzaki, Junko; Odunsi, Kunle.
Afiliação
  • Huang RY; Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA.
  • Eppolito C; Department of Immunology, Roswell Park Cancer Institute, Buffalo, New York, USA.
  • Lele S; Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA.
  • Shrikant P; Department of Immunology, Roswell Park Cancer Institute, Buffalo, New York, USA.
  • Matsuzaki J; Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA.
  • Odunsi K; Department of Research, Mayo Clinic, Scottsdale, Arizona, USA.
Oncotarget ; 6(29): 27359-77, 2015 Sep 29.
Article em En | MEDLINE | ID: mdl-26318293

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antígenos CD / Linfócitos T CD8-Positivos / Receptor de Morte Celular Programada 1 Limite: Animals Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antígenos CD / Linfócitos T CD8-Positivos / Receptor de Morte Celular Programada 1 Limite: Animals Idioma: En Ano de publicação: 2015 Tipo de documento: Article